SWM
AMPE

SVA Wealth Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

SVA Wealth Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$20K Buy
42
+9
+27% +$2.95K ﹤0.01% 229
2020
Q3 		$10K Buy
+33
New +$8.18K ﹤0.01% 210

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

SVA Wealth Management's AMPE Position: Q4 2020 in Review

SVA Wealth Management increased its Ampio Pharmaceuticals Inc. (AMPE) stake by 27% in Q4 2020, buying an estimated $2.95K and bringing the position to 42 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #229.

SVA Wealth Management first reported a position in AMPE in Q3 2020 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold AMPE as of Q4 2020.

  • SVA Wealth Management held 42 shares of Ampio Pharmaceuticals Inc. worth $20K as of Q4 2020.
  • SVA Wealth Management bought 9 Ampio Pharmaceuticals Inc. shares in Q4 2020, an estimated $2.95K.
  • Ampio Pharmaceuticals Inc. made up ﹤0.01% of SVA Wealth Management's portfolio in Q4 2020, its #229 holding.
  • SVA Wealth Management first reported a position in Ampio Pharmaceuticals Inc. in Q3 2020 and has held it in 2 quarters since.
  • 103 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2020.

Based on SVA Wealth Management's 13F filing for Q4 2020, filed 4 Feb 2021.